Case number 5:21-cv-03397
Novartis Pharmaceuticals Corporation v. Handa Neuroscience, LLC et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 29, 2022 | N/A | Remark (0) Docket Text: Remark :Case transferred from California Northernhas been opened in District of Delawareas case 1:22-cv-00352, filed 03/21/2022. (kmg, COURT STAFF) (Filed on 3/29/2022) |
| Mar 16, 2022 | 79 | Status Report (4) Docket Text: JOINT STATUS REPORT by Novartis Pharmaceuticals Corporation. (Love, Jane) (Filed on 3/16/2022) Modified on 3/16/2022 (kmg, COURT STAFF). |
| Mar 16, 2022 | 80 | Stipulation (6) Docket Text: STIPULATION WITH PROPOSED ORDER Transferring Case to the District of Delaware and Dismissing D.E. [28] and D.E. [73] as Moot filed by Novartis Pharmaceuticals Corporation. (Love, Jane) (Filed on 3/16/2022) |
| Mar 16, 2022 | 81 | Order on Motion to Shorten Time (6) Docket Text:ORDER denying as moot [73] Motion to Shorten Time; granting [80] Stipulation; denying as moot [28] Motion to Stay. Signed by Judge Edward J. Davila on March 16, 2022. The Clerk shall TRANSFER this action to the United States District Court for the District of Delaware. (ejdlc2, COURT STAFF) (Filed on 3/16/2022) |
| Mar 11, 2022 | 78 | Order (1) Docket Text:ORDER re Dkt. No. 77. Signed by Judge Edward J. Davila on March 11, 2022. The Court orders the Parties to submit a joint update by March 16, 2022.(ejdlc2, COURT STAFF) (Filed on 3/11/2022) |
| Mar 3, 2022 | 77 | Notice (Other) (30) Docket Text: JOINT NOTICE OF SUBSEQUENT DEVELOPMENTS by Novartis Pharmaceuticals Corporation (Love, Jane) (Filed on 3/3/2022) Modified on 3/4/2022 (kmg, COURT STAFF). |
| Feb 8, 2022 | 75 | Transcript (45) Docket Text: Transcript of Proceedings held on 02/01/2022, before Judge Susan Van Keulen. Court Reporter/Transcriber Summer Fisher, telephone number summer_fisher@cand.uscourts.gov. Per General Order No. 59 and Judicial Conference policy, this transcript may be viewed only at the Clerk's Office public terminal or may be purchased through the Court Reporter/Transcriber until the deadline for the Release of Transcript Restriction. After that date it may be obtained through PACER. Any Notice of Intent to Request Redaction, if required, is due no later than 5 business days from date of this filing. (Re [74] Transcript Order ) Redaction Request due 3/1/2022. Redacted Transcript Deadline set for 3/11/2022. Release of Transcript Restriction set for 5/9/2022. (Related documents(s) [74]) (Fisher, Summer) (Filed on 2/8/2022) |
| Feb 8, 2022 | 76 | Opposition/Response to Motion (6) Docket Text: OPPOSITION/RESPONSE (re [73] MOTION to Shorten Time ) filed byNovartis Pharmaceuticals Corporation. (Love, Jane) (Filed on 2/8/2022) |
| Feb 4, 2022 | 73 | Main Document (7) Docket Text: MOTION to Shorten Time filed by Handa Neuroscience, LLC, Handa Pharma, Inc., Handa Pharmaceuticals, Inc., Handa Pharmaceuticals, LLC. (Attachments: # (1) Declaration Declaration of Don Mizerk, # (2) Proposed Order)(Mizerk, Donald) (Filed on 2/4/2022) |
| Feb 4, 2022 | 73 | Declaration Declaration of Don Mizerk (13) |
| Feb 4, 2022 | 73 | Proposed Order (2) |
| Feb 4, 2022 | 74 | Transcript Order (2) Docket Text: TRANSCRIPT ORDER for proceedings held on February 1, 2022 before Magistrate Judge Susan van Keulen by Novartis Pharmaceuticals Corporation, for Court Reporter Summer Fisher. (Trenchard, Robert) (Filed on 2/4/2022) |
| Feb 3, 2022 | 72 | Protective Order (21) Docket Text:PROTECTIVE ORDER [60]. Signed by Judge Susan van Keulen on 2/3/2022. (svklc2, COURT STAFF) (Filed on 2/3/2022) |
| Feb 2, 2022 | 69 | Discovery Order (2) Docket Text:Order on Joint Discovery Submissions re Dkts. [59] [60] [61]. Signed by Judge Susan van Keulen on 2/2/2022. (svklc2, COURT STAFF) (Filed on 2/2/2022) |
| Feb 2, 2022 | 70 | Discovery Order (2) Docket Text:Order Directing Parties to Disclose Facts re ESI [59]. Signed by Judge Susan van Keulen on 2/2/2022. (svklc2, COURT STAFF) (Filed on 2/2/2022) |
| Feb 2, 2022 | 71 | Discovery Order (6) Docket Text:Order for Discovery of ESI [59]. Signed by Judge Susan van Keulen on 2/2/2022. (svklc2, COURT STAFF) (Filed on 2/2/2022) |
| Feb 1, 2022 | N/A | Discovery Hearing (0) Docket Text:Minute Entry for proceedings held before Magistrate Judge Susan van Keulen: Discovery Hearing held on 2/1/2022 via Zoom. Order(s) to issue. Total Time in Court: 10:00-11:07am (1 hour 7 mins). (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhf, COURT STAFF) (Date Filed: 2/1/2022) |
| Jan 31, 2022 | 67 | Main Document (1) Docket Text:TENTATIVE RULING REGARDING JOINT DISCOVERY SUBMISSION RE [DKT. [59]]. Signed by Judge Susan van Keulen on 1/31/22. (Attachments: # (1) Court Redline to Proposed Order 59-2 .) (jhf, COURT STAFF) (Filed on 1/31/2022) Modified on 1/31/2022 (sp, COURT STAFF). |
| Jan 31, 2022 | 67 | Exhibit Court Redline to Proposed Order 59-2 (9) |
| Jan 19, 2022 | N/A | Clerk's Notice (0) Docket Text: CLERK'S NOTICE: The parties are hereby notified that the Initial Case Management Conference is rescheduled to 4/7/2022 at 10:00 AM in San Jose, Courtroom 4, 5th Floor before Judge Edward J. Davila. An updated Case Management Statement is due by 3/28/2022. (This is a text-only entry generated by the court. There is no document associated with this entry.) (shy, COURT STAFF) (Filed on 1/19/2022) |
| Jan 19, 2022 | N/A | Clerk's Notice (0) Docket Text: CLERK'S NOTICE: The parties are hereby notified that the Initial Case Management Conference is rescheduled from 4/7/2022 to 4/14/2022 at 10:00 AM in San Jose, Courtroom 4, 5th Floor before Judge Edward J. Davila. An updated Case Management Statement is due by 4/4/2022. (This is a text-only entry generated by the court. There is no document associated with this entry.) (shy, COURT STAFF) (Filed on 1/19/2022) |
| Jan 18, 2022 | 64 | Case Management Statement (30) Docket Text: SECOND UPDATED JOINT CASE MANAGEMENT STATEMENT filed by Novartis Pharmaceuticals Corporation. (Love, Jane) (Filed on 1/18/2022) Modified on 1/20/2022 (gba, COURT STAFF). |
| Jan 7, 2022 | N/A | Clerk's Notice Setting Zoom Hearing. (0) Docket Text:CLERKS NOTICE SETTING ZOOM DISCOVERY HEARING. Discovery Hearing re [59],[60] and [61] set for 2/1/2022 10:00 AM in San Jose, - Videoconference Only before Magistrate Judge Susan van Keulen. This proceeding will be held via a Zoom webinar. Webinar Access: All counsel, members of the public, and media may access the webinar information at https://www.cand.uscourts.gov/svk Court Appearances: Advanced notice is required of counsel or parties who wish to be identified by the court as making an appearance or will be participating in the argument at the hearing. A list of names and emails must be sent to the CRD at SVKcrd@cand.uscourts.gov no later than January 31, 2022 at 12:00PM PST. General Order 58. Persons granted access to court proceedings held by telephone or videoconference are reminded that photographing, recording, and rebroadcasting of court proceedings, including screenshots or other visual copying of a hearing, is absolutely prohibited. Zoom Guidance and Setup:https://www.cand.uscourts.gov/zoom/. (This is a text-only entry generated by the court. There is no document associated with this entry.) (jhf, COURT STAFF) (Filed on 1/7/2022) |
| Jan 6, 2022 | 62 | Order on Motion to Shorten Time (1) Docket Text:ORDER by Judge Susan van Keulen denying as moot [51] Defendants' Motion to Shorten Time. (svklc2, COURT STAFF) (Filed on 1/6/2022) |
| Dec 23, 2021 | 61 | Main Document (8) Docket Text: Joint Discovery Letter Brief re Requests for Production and Interrogatories filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Love, Jane) (Filed on 12/23/2021) |
| Dec 23, 2021 | 61 | Exhibit A (33) |
| Dec 23, 2021 | 61 | Exhibit B (11) |
| Dec 23, 2021 | 61 | Exhibit C (39) |
| Dec 22, 2021 | 59 | Main Document (8) Docket Text: Joint Discovery Letter Brief re ESI ORDER filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Love, Jane) (Filed on 12/22/2021) |
| Dec 22, 2021 | 59 | Exhibit A (2) |
| Dec 22, 2021 | 59 | Exhibit B (8) |
| Dec 22, 2021 | 60 | Main Document (8) Docket Text: Joint Discovery Letter Brief re Protective Order filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A)(Love, Jane) (Filed on 12/22/2021) |
| Dec 22, 2021 | 60 | Exhibit A (22) |
| Nov 26, 2021 | 58 | Opposition/Response to Motion (7) Docket Text: OPPOSITION/RESPONSE (re [55] MOTION for Leave to File a Response and Supplemental Materials ) Defendants' Opposition to Novartis' Motion for Leave filed byHanda Neuroscience, LLC, Handa Pharma, Inc., Handa Pharmaceuticals, Inc., Handa Pharmaceuticals, LLC. (Mizerk, Donald) (Filed on 11/26/2021) |
| Nov 23, 2021 | 57 | Statement (5) Docket Text: Statement Opposing Novartis Pharmaceuticals Corporation's re [52] Notice of Pendency of Other Action Involving Same Patent by Handa Neuroscience, LLC, Handa Pharma, Inc., Handa Pharmaceuticals, Inc., Handa Pharmaceuticals, LLC. (Mizerk, Donald) (Filed on 11/23/2021) Modified on 11/29/2021 (gba, COURT STAFF). |
| Nov 22, 2021 | 55 | Main Document (4) Docket Text: MOTION for Leave to File a Response and Supplemental Materials filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Proposed Order, # (2) Declaration of R. Trenchard, # (3) Brief, # (4) Exhibit 1, # (5) Exhibit 2, # (6) Exhibit 3, # (7) Exhibit 4, # (8) Exhibit 5, # (9) Exhibit 6)(Love, Jane) (Filed on 11/22/2021) |
| Nov 22, 2021 | 55 | Proposed Order (2) |
| Nov 22, 2021 | 55 | Declaration of R. Trenchard (3) |
| Nov 22, 2021 | 55 | Brief (5) |
| Nov 22, 2021 | 55 | Exhibit 1 (32) |
| Nov 22, 2021 | 55 | Exhibit 2 (1) |
| Nov 22, 2021 | 55 | Exhibit 3 (1) |
| Nov 22, 2021 | 55 | Exhibit 4 (1) |
| Nov 22, 2021 | 55 | Exhibit 5 (1) |
| Nov 22, 2021 | 55 | Exhibit 6 (3) |
| Nov 22, 2021 | 56 | Main Document (3) Docket Text: Administrative Motion to File Under Seal ( re [55] MOTION for Leave to File a Response and Supplemental Materials ) filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Brief, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5)(Love, Jane) (Filed on 11/22/2021) |
| Nov 22, 2021 | 56 | *Restricted* (3) |
| Nov 22, 2021 | 56 | *Restricted* (3) |
| Nov 22, 2021 | 56 | *Restricted* (3) |
| Nov 22, 2021 | 56 | *Restricted* (3) |
| Nov 22, 2021 | 56 | *Restricted* (3) |
| Nov 22, 2021 | 56 | *Restricted* (3) |
| Nov 12, 2021 | 53 | Opposition/Response to Motion (6) Docket Text: OPPOSITION/RESPONSE (re [51] MOTION to Shorten Time Defendants' Local Rule 6-3 Motion to Shorten Time ) filed byNovartis Pharmaceuticals Corporation. (Love, Jane) (Filed on 11/12/2021) |
| Nov 12, 2021 | 54 | Main Document (2) Docket Text: Declaration of ROBERT W. TRENCHARD in Support of [53] Opposition/Response to Motion [51] to Shorten Time filed byNovartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit 1, R. Trenchard Decl, # (2) Exhibit 2, R. Trenchard Decl, # (3) Exhibit 3, R. Trenchard Decl)(Related document(s)[53]) (Love, Jane) (Filed on 11/12/2021) |
| Nov 12, 2021 | 54 | Exhibit 1, R. Trenchard Decl (5) |
| Nov 12, 2021 | 54 | Exhibit 2, R. Trenchard Decl (16) |
| Nov 12, 2021 | 54 | Exhibit 3, R. Trenchard Decl (5) |
| Nov 9, 2021 | 52 | Notice of Pendency of Other Action Involving Same Patent (3) Docket Text: NOTICE of Pendency of Other Action Involving Same Patent by Novartis Pharmaceuticals Corporation (Second Notice) (Love, Jane) (Filed on 11/9/2021) |
| Nov 8, 2021 | 50 | Main Document (4) Docket Text: NOTICE by Handa Neuroscience, LLC re [28] MOTION to Stay in Favor of First-Filed CaseNotice of Supplemental Authority Concerning Novartis' Motion to Stay (Attachments: # (1) Attachment A - Celgene)(Mizerk, Donald) (Filed on 11/8/2021) |
| Nov 8, 2021 | 50 | Attachment A - Celgene (30) |
| Nov 8, 2021 | 51 | Main Document (5) Docket Text: MOTION to Shorten Time Defendants' Local Rule 6-3 Motion to Shorten Time filed by Handa Neuroscience, LLC, Handa Pharma, Inc., Handa Pharmaceuticals, Inc., Handa Pharmaceuticals, LLC. (Attachments: # (1) Declaration of Don Mizerk In Support, # (2) Proposed Order)(Mizerk, Donald) (Filed on 11/8/2021) |
| Nov 8, 2021 | 51 | Declaration of Don Mizerk In Support (3) |
| Nov 8, 2021 | 51 | Proposed Order (1) |
| Nov 4, 2021 | 49 | Main Document (4) Docket Text: OPPOSITION/RESPONSE (re [28] MOTION to Stay in Favor of First-Filed Case ) Defendant Handa Neuroscience, LLC's Submission of Supplementary Materials In Support of Handa's Opposition to Novartis' Motion to Stay (D.I. 36) filed byHanda Neuroscience, LLC. (Attachments: # (1) Exhibit A - Correspondence, # (2) Exhibit B - FDA, # (3) Exhibit C - Dist. Del., # (4) Exhibit D - White House)(Mizerk, Donald) (Filed on 11/4/2021) |
| Nov 4, 2021 | 49 | Exhibit A - Correspondence (5) |
| Nov 4, 2021 | 49 | Exhibit B - FDA (5) |
| Nov 4, 2021 | 49 | Exhibit C - Dist. Del. (20) |
| Nov 4, 2021 | 49 | Exhibit D - White House (6) |
| Oct 29, 2021 | N/A | Clerk's Notice (0) Docket Text: CLERK'S NOTICE CONTINUING HEARING. Please take NOTICE that the Initial Case Management Conference set for 11/4/2021 is HEREBY CONTINUED to 1/27/2022 10:00 AM in San Jose, Courtroom 4, 5th Floor. Updated Joint Case Management Statement due by 1/18/2022. (This is a text-only entry generated by the court. There is no document associated with this entry.) (amk, COURT STAFF) (Filed on 10/29/2021) |
| Oct 25, 2021 | 47 | Main Document (37) Docket Text: CASE MANAGEMENT STATEMENT (Updated Joint) filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Blythe, Andrew) (Filed on 10/25/2021) |
| Oct 25, 2021 | 47 | Exhibit A (5) |
| Oct 25, 2021 | 47 | Exhibit B (20) |
| Oct 25, 2021 | 47 | Exhibit C (10) |
| Oct 4, 2021 | 46 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Andrew Philip Blythe (for Novartis Pharmaceuticals Corporation) (Blythe, Andrew) (Filed on 10/4/2021) |
| Sep 20, 2021 | N/A | Clerk's Notice (0) Docket Text: CLERK'S NOTICE CONTINUING HEARING. Please take NOTICE that the Initial Case Management Conference set for 9/30/2021 is HEREBY CONTINUED to 11/4/2021 10:00 AM in San Jose, Courtroom 4, 5th Floor. Joint Case Management Statement due by 10/25/2021. (This is a text-only entry generated by the court. There is no document associated with this entry.) (amkS, COURT STAFF) (Filed on 9/20/2021) |
| Aug 30, 2021 | N/A | Clerk's Notice (0) Docket Text: (Text Only) CLERKS NOTICE TAKING MOTIONS UNDER SUBMISSION WITHOUT ORAL ARGUMENT. The Motion for Judgment on the Pleadings (Docket Item No. [24]) and Motion to Stay (Docket Item No. [28]) before Judge Edward J. Davila previously noticed for 9/9/2021 at 9:00 AM have been taken under submission without oral argument pursuant to Civ. L.R. 7-1(b). The 9/9/2021 hearing is VACATED NO APPEARANCE NECESSARY. The Court to issue further Order on the submitted motions. This is a text only docket entry, there is no document associated with this notice. (amkS, COURT STAFF) (Filed on 8/30/2021) Modified on 8/30/2021 (amkS, COURT STAFF). |
| Aug 12, 2021 | 43 | Main Document (2) Docket Text: EXHIBITS re [41] Exhibits, [40] Reply to Opposition/Response filed byNovartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit 1, R. Trenchard Decl)(Related document(s)[41], [40]) (Trenchard, Robert) (Filed on 8/12/2021) |
| Aug 12, 2021 | 43 | Exhibit 1, R. Trenchard Decl (7) |
| Aug 11, 2021 | 40 | Main Document (11) Docket Text: REPLY (re [28] MOTION to Stay in Favor of First-Filed Case ) filed byNovartis Pharmaceuticals Corporation. (Attachments: # (1) Declaration of R. Trenchard)(Love, Jane) (Filed on 8/11/2021) |
| Aug 11, 2021 | 40 | Declaration of R. Trenchard (3) |
| Aug 11, 2021 | 41 | Main Document (3) Docket Text: EXHIBITS re [40] Reply to Opposition/Response (re [28] MOTION to Stay in Favor of First-Filed Case ) filed byNovartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit 1, R. Trenchard Decl, # (2) Exhibit 2, R. Trenchard Decl, # (3) Exhibit 3, R. Trenchard Decl, # (4) Exhibit 4, R. Trenchard Decl, # (5) Exhibit 5, R. Trenchard Decl, # (6) Exhibit 6, R. Trenchard Decl, # (7) Exhibit 7, R. Trenchard Decl)(Related document(s)[40]) (Love, Jane) (Filed on 8/11/2021) |
| Aug 11, 2021 | 41 | Exhibit 1, R. Trenchard Decl (1) |
| Aug 11, 2021 | 41 | Exhibit 2, R. Trenchard Decl (4) |
| Aug 11, 2021 | 41 | Exhibit 3, R. Trenchard Decl (3) |
| Aug 11, 2021 | 41 | Exhibit 4, R. Trenchard Decl (5) |
| Aug 11, 2021 | 41 | Exhibit 5, R. Trenchard Decl (5) |
| Aug 11, 2021 | 41 | Exhibit 6, R. Trenchard Decl (30) |
| Aug 11, 2021 | 41 | Exhibit 7, R. Trenchard Decl (77) |
| Aug 11, 2021 | 42 | Main Document (4) Docket Text: Administrative Motion to File Under Seal Documents in Support of [40] REPLY (re [28] MOTION to Stay in Favor of First-Filed Case ) filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Proposed Order, # (2) Declaration of R. Trenchard, # (3) REPLY (re [28] MOTION to Stay in Favor of First-Filed Case ) - Redacted, # (4) REPLY (re [28] MOTION to Stay in Favor of First-Filed Case ), # (5) Exhibit 6 (Redacted), # (6) Exhibit 6 (Unredacted), # (7) Exhibit 7 (Redacted), # (8) Exhibit 7 (Unredacted), # (9) Certificate/Proof of Service)(Love, Jane) (Filed on 8/11/2021) |
| Aug 11, 2021 | 42 | Proposed Order (3) |
| Aug 11, 2021 | 42 | Declaration of R. Trenchard (5) |
| Aug 11, 2021 | 42 | REPLY (re [28] MOTION to Stay in Favor of First-Filed Case ) - Redacted (11) |
| Aug 11, 2021 | 42 | *Restricted* (11) |
| Aug 11, 2021 | 42 | Exhibit 6 (Redacted) (30) |
| Aug 11, 2021 | 42 | *Restricted* (30) |
| Aug 11, 2021 | 42 | Exhibit 7 (Redacted) (77) |
| Aug 11, 2021 | 42 | *Restricted* (77) |
| Aug 11, 2021 | 42 | Certificate/Proof of Service (2) |
| Aug 3, 2021 | 39 | Reply to Opposition/Response (18) Docket Text: REPLY (re [24] MOTION for Judgment on the Pleadings ) Defendant Handa Neuroscience, LLC's Reply in Support of Motion for Judgment on the Pleadings filed byHanda Neuroscience, LLC. (Mizerk, Donald) (Filed on 8/3/2021) |
| Jul 28, 2021 | 36 | Opposition/Response to Motion (21) Docket Text: OPPOSITION/RESPONSE (re [28] MOTION to Stay in Favor of First-Filed Case ) filed byHanda Neuroscience, LLC. (Mizerk, Donald) (Filed on 7/28/2021) |
| Jul 28, 2021 | 37 | Main Document (4) Docket Text: DECLARATION of Don J. Mizerk in Opposition to [36] Opposition/Response to Motion filed byHanda Neuroscience, LLC. (Attachments: # (1) Exhibit A - Elan Pharma 21, # (2) Exhibit B - Elan Pharma Docket, # (3) Exhibit C - Law 360 Article, # (4) Exhibit D - July Email, # (5) Exhibit E - Production Letter, # (6) Exhibit F - Correspondence, # (7) Exhibit G - 11-2-2006 Order, # (8) Exhibit H - Opinion)(Related document(s)[36]) (Mizerk, Donald) (Filed on 7/28/2021) |
| Jul 28, 2021 | 37 | Exhibit A - Elan Pharma 21 (2) |
| Jul 28, 2021 | 37 | Exhibit B - Elan Pharma Docket (30) |
| Jul 28, 2021 | 37 | Exhibit C - Law 360 Article (4) |
| Jul 28, 2021 | 37 | Exhibit D - July Email (2) |
| Jul 28, 2021 | 37 | Exhibit E - Production Letter (3) |
| Jul 28, 2021 | 37 | Exhibit F - Correspondence (6) |
| Jul 28, 2021 | 37 | Exhibit G - 11-2-2006 Order (4) |
| Jul 28, 2021 | 37 | Exhibit H - Opinion (9) |
| Jul 28, 2021 | 38 | Declaration in Opposition (8) Docket Text: DECLARATION of Stephen Cary in Opposition to [36] Opposition/Response to Motion filed byHanda Neuroscience, LLC. (Related document(s)[36]) (Mizerk, Donald) (Filed on 7/28/2021) |
| Jul 27, 2021 | N/A | Clerk's Notice (0) Docket Text: CLERK'S NOTICE CONTINUING HEARING. Please take NOTICE that the Initial Case Management Conference set for 8/5/2021 is HEREBY CONTINUED to 9/30/2021 10:00 AM in San Jose, Courtroom 4, 5th Floor. Updated Joint Case Management Statement due by 9/20/2021. (This is a text-only entry generated by the court. There is no document associated with this entry.) (amkS, COURT STAFF) (Filed on 7/27/2021) |
| Jul 26, 2021 | 34 | Case Management Statement (27) Docket Text: CASE MANAGEMENT STATEMENT (Joint) filed by Novartis Pharmaceuticals Corporation. (Love, Jane) (Filed on 7/26/2021) |
| Jul 20, 2021 | 32 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Anne Yen-Chen Brody for Novartis Pharmaceuticals Corporation (Brody, Anne) (Filed on 7/20/2021) |
| Jul 20, 2021 | 33 | Opposition/Response to Motion (26) Docket Text: OPPOSITION/RESPONSE (re [24] MOTION for Judgment on the Pleadings ) filed byNovartis Pharmaceuticals Corporation. (Love, Jane) (Filed on 7/20/2021) |
| Jul 15, 2021 | 31 | ADR Certification (ADR L.R. 3-5 b)of discussion of ADR options (1) Docket Text: ADR Certification (ADR L.R. 3-5 b) of discussion of ADR options (Hsin, Yu-Chieh) (Filed on 7/15/2021) |
| Jun 30, 2021 | 30 | Order on Stipulation (5) Docket Text: Order Granting [29] Stipulation Extending Briefing Schedule for Plaintiff's Motion to Stay. Signed by Judge Edward J. Davila on 06/30/2021. (ejdlc2S, COURT STAFF) (Filed on 6/30/2021) |
| Jun 29, 2021 | 29 | Stipulation (5) Docket Text: STIPULATION WITH PROPOSED ORDER re [28] MOTION to Stay in Favor of First-Filed Case (Extending Briefing Schedule) filed by Novartis Pharmaceuticals Corporation. (Hsin, Yu-Chieh) (Filed on 6/29/2021) |
| Jun 22, 2021 | N/A | Set Deadlines/Hearings (0) Docket Text: ***Set Deadlines/Hearings as to [24] MOTION for Judgment on the Pleadings per [27] Order: Plaintiff's opposition due by 7/20/2021. Handa Neuroscience, LLC's reply due by 8/3/2021. (kedS, COURT STAFF) (Filed on 6/22/2021) |
| Jun 22, 2021 | 27 | Order on Stipulation (4) Docket Text: Order Granting [26] Stipulation Extending Briefing Schedule for Motion for Judgment on the Pleadings. Signed by Judge Edward J. Davila on 06/22/2021. (ejdlc2S, COURT STAFF) (Filed on 6/22/2021) |
| Jun 22, 2021 | 28 | Main Document (18) Docket Text: MOTION to Stay in Favor of First-Filed Case filed by Novartis Pharmaceuticals Corporation. Motion Hearing set for 9/9/2021 09:00 AM in San Jose, Courtroom 4, 5th Floor before Judge Edward J. Davila. Responses due by 7/6/2021. Replies due by 7/13/2021. (Attachments: # (1) Declaration of R. Trenchard, # (2) Exhibit 1, Trenchard Decl., # (3) Exhibit 2, Trenchard Decl., # (4) Exhibit 3, Trenchard Decl., # (5) Exhibit 4, Trenchard Decl., # (6) Exhibit 5, Trenchard Decl., # (7) Exhibit 6, Trenchard Decl., # (8) Exhibit 7, Trenchard Decl., # (9) Exhibit 8, Trenchard Decl., # (10) Proposed Order)(Hsin, Yu-Chieh) (Filed on 6/22/2021) |
| Jun 22, 2021 | 28 | Declaration of R. Trenchard (3) |
| Jun 22, 2021 | 28 | Exhibit 1, Trenchard Decl. (26) |
| Jun 22, 2021 | 28 | Exhibit 2, Trenchard Decl. (45) |
| Jun 22, 2021 | 28 | Exhibit 3, Trenchard Decl. (103) |
| Jun 22, 2021 | 28 | Exhibit 4, Trenchard Decl. (14) |
| Jun 22, 2021 | 28 | Exhibit 5, Trenchard Decl. (10) |
| Jun 22, 2021 | 28 | Exhibit 6, Trenchard Decl. (18) |
| Jun 22, 2021 | 28 | Exhibit 7, Trenchard Decl. (4) |
| Jun 22, 2021 | 28 | Exhibit 8, Trenchard Decl. (3) |
| Jun 22, 2021 | 28 | Proposed Order (2) |
| Jun 21, 2021 | 26 | Stipulation (4) Docket Text: STIPULATION WITH PROPOSED ORDER re [24] MOTION for Judgment on the Pleadings (Extending Briefing Schedule) filed by Novartis Pharmaceuticals Corporation. (Hsin, Yu-Chieh) (Filed on 6/21/2021) |
| Jun 15, 2021 | 23 | Answer to Complaint (27) Docket Text: ANSWER to Complaint byHanda Neuroscience, LLC, Handa Pharma, Inc., Handa Pharmaceuticals, Inc., Handa Pharmaceuticals, LLC. (Mizerk, Donald) (Filed on 6/15/2021) |
| Jun 15, 2021 | 24 | Motion for Judgment on the Pleadings (27) Docket Text: MOTION for Judgment on the Pleadings filed by Handa Neuroscience, LLC. Motion Hearing set for 9/9/2021 09:00 AM in San Jose, Courtroom 4, 5th Floor before Judge Edward J. Davila. Responses due by 6/29/2021. Replies due by 7/6/2021. (Mizerk, Donald) (Filed on 6/15/2021) |
| Jun 15, 2021 | 25 | Main Document (3) Docket Text: Declaration of Don J. Mizert in Support of [24] MOTION for Judgment on the Pleadings filed byHanda Neuroscience, LLC. (Attachments: # (1) Exhibit 1 - '179 Pros. History, # (2) Exhibit 2 - Garber, # (3) Exhibit 3 - Tyler, # (4) Exhibit 4 - Arvin, # (5) Exhibit 5 - VARIVAX Label, # (6) Exhibit 6 - Physicians' Desk Ref., # (7) Exhibit 7 - ZOSTAVAX Label, # (8) Exhibit WO2008000419A1, # (9) Exhibit Schmouder)(Related document(s)[24]) (Mizerk, Donald) (Filed on 6/15/2021) |
| Jun 15, 2021 | 25 | Exhibit 1 - '179 Pros. History (379) |
| Jun 15, 2021 | 25 | Exhibit 2 - Garber (3) |
| Jun 15, 2021 | 25 | Exhibit 3 - Tyler (5) |
| Jun 15, 2021 | 25 | Exhibit 4 - Arvin (21) |
| Jun 15, 2021 | 25 | Exhibit 5 - VARIVAX Label (16) |
| Jun 15, 2021 | 25 | Exhibit 6 - Physicians' Desk Ref. (7) |
| Jun 15, 2021 | 25 | Exhibit 7 - ZOSTAVAX Label (24) |
| Jun 15, 2021 | 25 | Exhibit WO2008000419A1 (23) |
| Jun 15, 2021 | 25 | Exhibit Schmouder (3) |
| Jun 14, 2021 | 21 | Notice of Appearance (3) Docket Text: NOTICE of Appearance by Donald J Mizerk (Mizerk, Donald) (Filed on 6/14/2021) |
| Jun 14, 2021 | 22 | Certificate of Interested Entities (2) Docket Text: Certificate of Interested Entities by Handa Neuroscience, LLC, Handa Pharma, Inc., Handa Pharmaceuticals, Inc., Handa Pharmaceuticals, LLC identifying Corporate Parent Handa Pharmaceuticals, Inc. for Handa Neuroscience, LLC, Handa Pharma, Inc., Handa Pharmaceuticals, LLC. (Mizerk, Donald) (Filed on 6/14/2021) |
| May 21, 2021 | 20 | Order on Stipulation (5) Docket Text: Order Granting [19] Stipulation Governing Acceptance of Service of Process and Response Time to Complaint. Signed by Judge Edward J. Davila on 05/21/2021. (ejdlc2S, COURT STAFF) (Filed on 5/21/2021) |
| May 20, 2021 | 19 | Stipulation (5) Docket Text: STIPULATION WITH PROPOSED ORDER Governing Acceptance of Service of Process and Response Time to Complaint filed by Novartis Pharmaceuticals Corporation. (Hsin, Yu-Chieh) (Filed on 5/20/2021) |
| May 18, 2021 | 17 | Main Document (1) Docket Text:ORDER REASSIGNING CASE. Case reassigned using a proportionate, random, and blind system pursuant to General Order No. 44 to Judge Edward J. Davila for all further proceedings. Magistrate Judge Laurel Beeler no longer assigned to case, Notice: The assigned judge participates in the Cameras in the Courtroom Pilot Project. See General Order No. 65 and http://cand.uscourts.gov/cameras.. Signed by Clerk on 05/18/2021. (Attachments: # (1) Notice of Eligibility for Video Recording)(mbcS, COURT STAFF) (Filed on 5/18/2021) |
| May 18, 2021 | 17 | Notice of Eligibility for Video Recording (1) |
| May 18, 2021 | N/A | Clerk's Notice (0) Docket Text: (Text Only) CLERKS NOTICE RESETTING CASE MANAGEMENT CONFERENCE FOLLOWING REASSIGNMENT. Joint Case Management Statement due by 7/26/2021. Initial Case Management Conference set for 8/5/2021 10:00 AM in San Jose, Courtroom 4, 5th Floor before Hon. Edward J. Davila. The Court does not issue a revised Initial Case Management Scheduling Order with ADR Deadlines. Standing orders can be downloaded from the court's web page at http://cand.uscourts.gov/ejdorders. This is a text only docket entry, there is no document associated with this notice. (amkS, COURT STAFF) (Filed on 5/18/2021) |
| May 17, 2021 | 15 | Consent/Declination to Proceed Before a US Magistrate Judge (1) Docket Text: CONSENT/DECLINATION to Proceed Before a US Magistrate Judge by Novartis Pharmaceuticals Corporation.. (Love, Jane) (Filed on 5/17/2021) |
| May 17, 2021 | N/A | Clerk's Notice of Impending Reassignment - Text Only (0) Docket Text: CLERK'S NOTICE OF IMPENDING REASSIGNMENT TO A U.S. DISTRICT COURT JUDGE: The Clerk of this Court will now randomly reassign this case to a District Judge because either (1) a party has not consented to the jurisdiction of a Magistrate Judge, or (2) time is of the essence in deciding a pending judicial action for which the necessary consents to Magistrate Judge jurisdiction have not been secured. You will be informed by separate notice of the district judge to whom this case is reassigned. ALL HEARING DATES PRESENTLY SCHEDULED BEFORE THE CURRENT MAGISTRATE JUDGE ARE VACATED AND SHOULD BE RE-NOTICED FOR HEARING BEFORE THE JUDGE TO WHOM THIS CASE IS REASSIGNED. This is a text only docket entry; there is no document associated with this notice. (ejkS, COURT STAFF) (Filed on 5/17/2021) |
| May 13, 2021 | 11 | Main Document (1) Docket Text: MOTION for leave to appear in Pro Hac Vice for Novartis Pharmaceuticals Corporation ( Filing fee $ 317, receipt number 0971-15961378.) filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Certificate of Good Standing)(Love, Jane) (Filed on 5/13/2021) |
| May 13, 2021 | 11 | Certificate of Good Standing (2) |
| May 13, 2021 | 12 | Main Document (1) Docket Text: MOTION for leave to appear in Pro Hac Vice for Novartis Pharmaceuticals Corporation ( Filing fee $ 317, receipt number 0971-15962038.) filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Certificate of Good Standing)(Trenchard, Robert) (Filed on 5/13/2021) |
| May 13, 2021 | 12 | Certificate of Good Standing (2) |
| May 13, 2021 | 13 | Order on Motion for Pro Hac Vice (3) Docket Text:Order by Magistrate Judge Laurel Beeler granting [11] Motion for Pro Hac Vice. Attorney Jane M Love representing Plaintiff. (ejkS, COURT STAFF) (Filed on 5/13/2021) |
| May 13, 2021 | 14 | Order on Motion for Pro Hac Vice (3) Docket Text:Order by Magistrate Judge Laurel Beeler granting [12] Motion for Pro Hac Vice. Attorney Robert W Trenchard representing Plaintiff. (ejkS, COURT STAFF) (Filed on 5/13/2021) |
| May 11, 2021 | 9 | Initial Case Management Scheduling Order with ADR Deadlines (2) Docket Text:Initial Case Management Scheduling Order with ADR Deadlines: Case Management Statement due by 7/29/2021. Initial Case Management Conference set for 8/5/2021 11:00 AM in San Francisco, Courtroom B, 15th Floor. (gbaS, COURT STAFF) (Filed on 5/11/2021) |
| May 11, 2021 | 10 | Summons Issued (8) Docket Text: Summons Issued as to Handa Neuroscience, LLC, Handa Pharma, Inc., Handa Pharmaceuticals, Inc., Handa Pharmaceuticals, LLC. (gbaS, COURT STAFF) (Filed on 5/11/2021) |
| May 7, 2021 | N/A | Case Assigned by Intake (0) Docket Text: Case assigned to Magistrate Judge Laurel Beeler. Counsel for plaintiff or the removing party is responsible for serving the Complaint or Notice of Removal, Summons and the assigned judge's standing orders and all other new case documents upon the opposing parties. For information, visit E-Filing A New Civil Case at http://cand.uscourts.gov/ecf/caseopening. Standing orders can be downloaded from the court's web page at www.cand.uscourts.gov/judges. Upon receipt, the summons will be issued and returned electronically. Counsel is required to send chambers a copy of the initiating documents pursuant to L.R. 5-1(e)(7). A scheduling order will be sent by Notice of Electronic Filing (NEF) within two business days. Consent/Declination due by 5/21/2021. (haS, COURT STAFF) (Filed on 5/7/2021) |
| May 6, 2021 | 1 | *Restricted* (0) Docket Text:**Erroneous Entry - please disregard and refer to Docket No. [7]** COMPLAINT for Patent Infringement against All Defendants (Filing fee $ 402, receipt number 0971-15936857.). Filed byNovartis Pharmaceuticals Corporation. (Attachments: # (1) Civil Cover Sheet)(Hsin, Yu-Chieh) (Filed on 5/6/2021) Modified on 5/10/2021 (gbaS, COURT STAFF). |
| May 6, 2021 | 1 | Civil Cover Sheet (2) |
| May 6, 2021 | 2 | Main Document (2) Docket Text: Proposed Summons. (Attachments: # (1) Summons (Handa Pharmaceuticals Inc), # (2) Summons (Handa Pharma Inc), # (3) Summons (Handa Pharmaceuticals LLC))(Hsin, Yu-Chieh) (Filed on 5/6/2021) |
| May 6, 2021 | 2 | Summons (Handa Pharmaceuticals Inc) (2) |
| May 6, 2021 | 2 | Summons (Handa Pharma Inc) (2) |
| May 6, 2021 | 2 | Summons (Handa Pharmaceuticals LLC) (2) |
| May 6, 2021 | 3 | Patent/Trademark Report (1) Docket Text: REPORT on the filing of an action regarding Patent Nos. 9,187,405 and 10,543,179 (cc: form mailed to register). (Hsin, Yu-Chieh) (Filed on 5/6/2021) Modified on 5/11/2021 (gbaS, COURT STAFF). |
| May 6, 2021 | 4 | Certificate of Interested Entities (2) Docket Text: Certificate of Interested Entities by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (Hsin, Yu-Chieh) (Filed on 5/6/2021) |
| May 6, 2021 | 5 | Notice of Pendency of Other Action Involving Same Patent (3) Docket Text: NOTICE of Pendency of Other Action Involving Same Patent by Novartis Pharmaceuticals Corporation (Hsin, Yu-Chieh) (Filed on 5/6/2021) |
| May 6, 2021 | 6 | Notice (Other) (2) Docket Text: NOTICE of Errata by Novartis Pharmaceuticals Corporation re [1] Complaint (Hsin, Yu-Chieh) (Filed on 5/6/2021) Modified on 5/11/2021 (gbaS, COURT STAFF). |
| May 6, 2021 | 7 | Main Document (20) Docket Text: CORRECTED COMPLAINT for Patent Infringement (replacing document [1] ) against All Defendants. Filed byNovartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A, Complaint, # (2) Exhibit B, Complaint, # (3) Exhibit C, Complaint, # (4) Civil Cover Sheet)(Hsin, Yu-Chieh) (Filed on 5/6/2021) Modified on 5/10/2021 (gbaS, COURT STAFF). |
| May 6, 2021 | 7 | Exhibit A, Complaint (12) |
| May 6, 2021 | 7 | Exhibit B, Complaint (17) |
| May 6, 2021 | 7 | Exhibit C, Complaint (33) |
| May 6, 2021 | 7 | Civil Cover Sheet (2) |
